Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MemAID: Intranasal Insulin for Memory in Type 2 Diabetes
NCT02415556Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2015
- Primary completion
- May 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of intranasal insulin in type 2 diabetes mellitus (T2DM), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2015; status: completed.
02
Drugs
intranasal insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02415556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415556.